Applied Therapeutics, Inc. (APLT)
NASDAQ: APLT · Real-Time Price · USD
0.5029
-0.0134 (-2.60%)
Mar 31, 2025, 10:53 AM EDT - Market open
Applied Therapeutics Stock Forecast
APLT's stock price has decreased by -92.6% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Applied Therapeutics stock have an average target of 6.10, with a low estimate of 1.50 and a high estimate of 14. The average target predicts an increase of 1,112.96% from the current stock price of 0.50.
Analyst Consensus: Buy
* Price targets were last updated on Dec 20, 2024.
Analyst Ratings
The average analyst rating for Applied Therapeutics stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 1 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Dec 23, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $4 → $1.5 | Hold | Maintains | $4 → $1.5 | +198.27% | Dec 20, 2024 |
| UBS | UBS | Strong Buy → Hold Downgrades $13 → $2 | Strong Buy → Hold | Downgrades | $13 → $2 | +297.69% | Dec 2, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $13 → $8 | Strong Buy | Maintains | $13 → $8 | +1,490.77% | Nov 29, 2024 |
| Baird | Baird | Buy Maintains $14 → $5 | Buy | Maintains | $14 → $5 | +894.23% | Nov 29, 2024 |
Financial Forecast
Revenue This Year
564.06K
from 9.99M
Decreased by -94.36%
Revenue Next Year
14.25M
from 564.06K
Increased by 2,426.33%
EPS This Year
-1.32
from -1.42
EPS Next Year
-0.63
from -1.32
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 840,000 | 41.4M | 81.6M | |||
| Avg | 564,060 | 14.3M | 58.7M | |||
| Low | 446,880 | 766,360 | 39.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -91.6% | 7,234.3% | 472.7% | |||
| Avg | -94.4% | 2,426.3% | 312.0% | |||
| Low | -95.5% | 35.9% | 179.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.35 | -0.55 | -0.34 | |||
| Avg | -1.32 | -0.63 | -0.46 | |||
| Low | -1.27 | -0.70 | -0.56 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.